State Street Corp Stoke Therapeutics, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,587,663 shares of STOK stock, worth $13.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,587,663

Previous 1,728,888 8.17%

Holding current value

$13.2 Million

Previous $21.2 Million 17.59%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$10.8 - $13.92 $1.53 Million - $1.97 Million	-141,225 Reduced 8.17%	1,587,663 $17.5 Million
Q3 2024 Nov 14, 2024	BUY	$12.24 - $15.92 $1.68 Million - $2.18 Million	137,145 Added 8.62%	1,728,888 $21.2 Million
Q2 2024 Aug 14, 2024	BUY	$11.03 - $17.52 $11.2 Million - $17.7 Million	1,012,136 Added 174.62%	1,591,743 $21.5 Million
Q1 2024 May 15, 2024	BUY	$4.12 - $14.17 $148,624 - $511,168	36,074 Added 6.64%	579,607 $7.82 Million
Q4 2023 Feb 14, 2024	SELL	$3.37 - $5.4 $143,140 - $229,365	-42,475 Reduced 7.25%	543,533 $2.86 Million
Q3 2023 Nov 14, 2023	BUY	$3.78 - $11.99 $129,752 - $411,568	34,326 Added 6.22%	586,008 $2.31 Million
Q2 2023 Aug 14, 2023	BUY	$7.93 - $13.82 $1.03 Million - $1.8 Million	130,054 Added 30.85%	551,682 $5.86 Million
Q1 2023 May 15, 2023	BUY	$7.65 - $10.38 $60,274 - $81,784	7,879 Added 1.9%	421,628 $3.51 Million
Q4 2022 Feb 14, 2023	BUY	$7.07 - $15.69 $15,971 - $35,443	2,259 Added 0.55%	413,749 $3.82 Million
Q3 2022 Nov 15, 2022	BUY	$12.56 - $22.53 $369,063 - $662,021	29,384 Added 7.69%	411,490 $5.28 Million
Q2 2022 Aug 15, 2022	SELL	$10.36 - $23.93 $5.93 Million - $13.7 Million	-571,919 Reduced 59.95%	382,106 $5.05 Million
Q1 2022 May 16, 2022	BUY	$17.19 - $26.1 $2.7 Million - $4.1 Million	157,173 Added 19.72%	954,025 $20.1 Million
Q4 2021 Feb 14, 2022	SELL	$18.11 - $30.72 $2.13 Million - $3.62 Million	-117,819 Reduced 12.88%	796,852 $19.1 Million
Q3 2021 Nov 15, 2021	BUY	$23.65 - $34.44 $232,597 - $338,717	9,835 Added 1.09%	914,671 $23.3 Million
Q2 2021 Aug 16, 2021	BUY	$30.53 - $41.09 $4.81 Million - $6.47 Million	157,548 Added 21.08%	904,836 $30.5 Million
Q1 2021 May 17, 2021	BUY	$36.08 - $69.81 $11.3 Million - $21.9 Million	313,180 Added 72.14%	747,288 $29 Million
Q4 2020 Feb 16, 2021	BUY	$33.62 - $61.93 $6.88 Million - $12.7 Million	204,696 Added 89.23%	434,108 $26.9 Million
Q3 2020 Nov 10, 2020	SELL	$22.23 - $37.48 $838,671 - $1.41 Million	-37,727 Reduced 14.12%	229,412 $7.68 Million
Q2 2020 Aug 14, 2020	SELL	$20.26 - $29.73 $549,896 - $806,931	-27,142 Reduced 9.22%	267,139 $6.37 Million
Q1 2020 May 11, 2020	BUY	$16.8 - $34.15 $4.94 Million - $10 Million	294,281 New	294,281 $6.74 Million

Others Institutions Holding STOK

# of Institutions

136

Shares Held

57.3M

Call Options Held

5.7K

Put Options Held

24.4K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $328M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Stoke Therapeutics, Inc. Transaction History